Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AG011 in Moderately Active Ulcerative Colitis
NCT00729872Phase 2Completed
- Sponsor
- ActoBio Therapeutics
- Start
- Jul 2008
- Primary completion
- Sep 2009
- Modality
- Cytokines & Interferons, Live Biotherapeutic Products
- Countries
- 4
01
Overview
A Phase 2 trial of AG011 in ulcerative colitis (UC), sponsored by ActoBio Therapeutics. Started Jul 2008; status: completed.
02
Drugs
AG011
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00729872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729872.